Ardelyx, Inc. ARDX was a big mover last session, as the company saw its shares rise over 6% on the day. The company announced the pricing of a secondary offering of 7.5 million shares, which led to solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend for the company as the stock is roughly down about 39.4% in the past one-month time frame.
In the last 30 days, this company did not witness any estimate revisions and the Zacks Consensus Estimate has remained unchanged over the same period. However, the recent price action is encouraging, so make sure to keep a close watch on this firm in the near future.
Ardelyx currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
A well-ranked player in the same industry includes Aerie Pharmaceuticals, Inc. AERI carrying a Zacks Rank #1 (Strong Buy).
Is ARDX going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment